問卷

TPIDB > Principal Investigator

Principal Investigator


Taichung Veterans General Hospital (在職)

Division of Cardiovascular Diseases

更新時間:2023-09-19

何鴻鋆
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

4Cases

2026-09-01 - 2029-06-30

Phase II

Not yet recruiting
A phase 2, randomized, double-blind, placebo-controlled trial was conducted to evaluate the efficacy, safety, and tolerability of CRD-4730 in patients with heart failure with reduced ejection fraction (HFrEF).
  • Condition/Disease

    Heart failure with reduced ejection fraction

  • Test Drug

    CRD-4730

Participate Sites
4Sites

Not yet recruiting4Sites

2024-07-30 - 2028-09-30

Phase III

Active
-
  • Condition/Disease

    -

  • Test Drug

    -

Participate Sites
12Sites

Not yet recruiting8Sites

Recruiting4Sites

2025-05-01 - 2029-06-30

Active
  • Condition/Disease

  • Test Drug

Participate Sites
8Sites

Recruiting8Sites

2014-01-01 - 2016-12-31

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
8Sites

Terminated8Sites